{"entity":{"id":"nct06902389","kind":"trial","name":"A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma","aka":[],"tldr":"A trial tests engineered T cells that can target several tumor proteins, including TROP2. Its activity cannot be attributed to TROP2 targeting alone.","summary":"A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma. ClinicalTrials.gov record last updated 2025-09-03: recruiting. Enrollment is planned at 30 participants. Primary completion is estimated at 2028-01-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.","status":"recruiting","asOf":"2026-10-06","links":[{"label":"ClinicalTrials.gov NCT06902389","url":"https://clinicaltrials.gov/study/NCT06902389"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":["trop2"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["ClinicalTrials.gov record last updated 2025-09-03: recruiting. Enrollment is planned at 30 participants. Primary completion is estimated at 2028-01-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications."],"nct":"NCT06902389","phase":"1/2","setting":"A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma","sponsor":"Eastern Hepatobiliary Surgery Hospital","started":"2025-07-30","startedType":"actual","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06902389/","neighbours":{"target":[{"id":"trop2","kind":"target","name":"TROP2","route":"/targets/trop2/"}]}}